Jaafar Bennouna
Department of Medical Oncology
Centre René Gauducheau
44805
Nantes-Saint-Herblain
France
Name/email consistency: high
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors. Bennouna, J., Levy, V., Sicard, H., Senellart, H., Audrain, M., Hiret, S., Rolland, F., Bruzzoni-Giovanelli, H., Rimbert, M., Galéa, C., Tiollier, J., Calvo, F. Cancer Immunol. Immunother. (2010)
- The role of UFT in metastatic colorectal cancer. Bennouna, J., Saunders, M., Douillard, J.Y. Oncology (2009)
- Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Bennouna, J., Bompas, E., Neidhardt, E.M., Rolland, F., Philip, I., Galéa, C., Salot, S., Saiagh, S., Audrain, M., Rimbert, M., Lafaye-de Micheaux, S., Tiollier, J., Négrier, S. Cancer Immunol. Immunother. (2008)
- Vinflunine: a new microtubule inhibitor agent. Bennouna, J., Delord, J.P., Campone, M., Nguyen, L. Clin. Cancer Res. (2008)
- Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study. Bennouna, J., Breton, J.L., Tourani, J.M., Ottensmeier, C., O'Brien, M., Kosmidis, P., Huat, T.E., Pinel, M.C., Colin, C., Douillard, J.Y. Br. J. Cancer (2006)
- 'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'. Bennouna, J., Perrier, H., Paillot, B., Priou, F., Jacob, J.H., Hebbar, M., Bordenave, S., Seitz, J.F., Cvitkovic, F., Dorval, E., Malek, K., Tonelli, D., Douillard, J.Y. Br. J. Cancer (2006)
- Vinflunine: a novel antitubulin agent in solid malignancies. Bennouna, J., Campone, M., Delord, J.P., Pinel, M.C. Expert. Opin. Investig. Drugs (2005)
- A phase II study with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4 regimen) in patients with metastatic renal cell carcinoma. Bennouna, J., Delva, R., Gomez, F., Lesimple, T., Geoffrois, L., Linassier, C., Chevreau, C., Douillard, J.Y., Négrier, S. Oncology (2003)
- Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours. Bennouna, J., Fumoleau, P., Armand, J.P., Raymond, E., Campone, M., Delgado, F.M., Puozzo, C., Marty, M. Ann. Oncol. (2003)
- Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapy. Bennouna, J., Douillard, J.Y. Expert. Rev. Anticancer. Ther (2003)
